e-learning
resources
Virtual 2020
Pre-Congress Content
Phenotyping sleep-disordered breathing and its impact on various diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Is there a mortality disadvantage in tracheobronchomalacia?
N. Nwosu (Liverpool (Merseyside), United Kingdom), H. Burhan (Liverpool (Merseyside), United Kingdom), A. Manuel (Liverpool (Merseyside), United Kingdom)
Source:
Virtual Congress 2020 – Phenotyping sleep-disordered breathing and its impact on various diseases
Session:
Phenotyping sleep-disordered breathing and its impact on various diseases
Session type:
E-poster session
Number:
2948
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. Nwosu (Liverpool (Merseyside), United Kingdom), H. Burhan (Liverpool (Merseyside), United Kingdom), A. Manuel (Liverpool (Merseyside), United Kingdom). Is there a mortality disadvantage in tracheobronchomalacia?. 2948
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Risk factors for early mortality and morbidity after pneumonectomy: a reappraisal
Source: Annual Congress 2008 - Risk assessment and treatment of complications in thoracic surgery patients
Year: 2008
Factors affecting mortality and morbidity in patients with bronchiectasis
Source: Annual Congress 2010 - Lung morbidity on exposure to various agents
Year: 2010
Mortality in bronchiectasis: a long-term study assessing the factors influencing survival
Source: Eur Respir J 2009; 34: 843-849
Year: 2009
Mortality: a neglected outcome in OCS-treated severe asthma
Source: Eur Respir J, 50 (5) 1701486; 10.1183/13993003.01486-2017
Year: 2017
Reducing childhood respiratory morbidity and mortality in low and middle income countries: a current challenge
Source: Eur Respir J, 54 (1) 1900987; 10.1183/13993003.00987-2019
Year: 2019
Does “poor asthma control” influence morbidity and cost of care in the following year?
Source: Eur Respir J 2001; 18: Suppl. 33, 401s
Year: 2001
Long-term impact of COPD on postoperative cardiorespiratory morbidity and mortality: a population cohort study
Source: Virtual Congress 2021 – Patient-reported outcome measures (PROMs): easy tools in the management of chronic respiratory diseases
Year: 2021
The problem of early mortality in pneumococcal pneumonia: a study of risk factors
Source: Eur Respir J 2015; 46: 561-564
Year: 2015
Affecting mortality in COPD: Is the dream becoming a reality?
Source: Annual Congress 2006 - The TORCH survival study. Affecting mortality in COPD: Is the dream becoming a reality?
Year: 2006
The impact on risk-factor analysis of different mortality outcomes in COPD patients
Source: Eur Respir J 2008; 32: 629-636
Year: 2008
Asthma, airflow limitation and mortality risk in the general population
Source: Eur Respir J 2015; 45: 338-346
Year: 2015
Breast feeding and infant mortality from acute respiratory infections: estimation of preventable deaths
Source: Annual Congress 2008 - Paediatric respiratory epidemiology II: air pollution studies and infectious disease epidemiology
Year: 2008
Analysis of causes of death and mortality risk factors in elderly patients hospitalized due to pneumonia
Source: International Congress 2018 – Difficult-to-treat respiratory infections
Year: 2018
Deaths in risk classes I-III: a measure of quality of care in patients hospitalised with CAP?
Source: Eur Respir J 2004; 23: 103-105
Year: 2004
Impact of intermittent hypoxia on cardiovascular morbidity and mortality
Source: Research Seminar 2005 - Adaptations to Hypoxia
Year: 2005
Can infant lung function predict respiratory morbidity during the first year of life in preterm infants?
Source: Eur Respir J 2014; 43: 1642-1651
Year: 2014
Potential causes of increased long-term mortality after pneumonia
Source: Eur Respir J 2011; 37: 1306-1307
Year: 2011
Smoking Cessation, the most cost effective intervention for the most preventable mortality and morbidity burden
Source: International Congress 2017 – Hot topic on tobacco prevention and cessation
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept